InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test.
InnoCare Pharma
HKEX: 09969 TBD MCAP
InnoCare is a biologics company covered in the openbionews harvest.
InnoCare is a biologics company covered in the openbionews harvest.
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test.